Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 1, 1996
Preclinical development of antiviral drugsG M SzczechFundamental and Applied Toxicology : Official Journal of the Society of Toxicology|February 11, 1992
Neurotoxic effects of the anti-varicella zoster virus agent 2'-valeryl-6-methoxypurine arabinoside in monkeys and rats dosed orally for 90 daysG M Szczech, W E TuckerToxicologic Pathology|January 1, 1983
Dose selection as it pertains to testing a prodrug in carcinogenicity bioassaysG M Szczech, W E TuckerCurrent Opinion in Drug Discovery & Development|August 4, 2009
Screening for potential toxicity of antiviral therapiesG M Szczech, P A FurmanToxicologic Pathology|January 1, 1985
Nail loss and footpad erosions in beagle dogs given BW 134U, a nucleoside analogG M Szczech, W E TuckerTeratology|February 1, 1978
Effects in mice of simultaneous prenatal exposure to ochratoxin A and T-2 toxinR D Hood, M H Kuczuk, G M SzczechAdvances in Prostaglandin and Thromboxane Research|January 1, 1978
Preclinical safety evaluation of 15[S]15-methyl prostaglandin F2alpha : reproduction and teratologyG M Szczech, B P Purmalis, S B HarrisTeratology|June 1, 1983
Postnatal behavioral effects of ochratoxin A in offspring of treated miceS M Poppe, J L Stuckhardt, G M SzczechAntimicrobial Agents and Chemotherapy|May 1, 1992
Inactivators of herpes simplex virus ribonucleotide reductase: hematological profiles and in vivo potentiation of the antiviral activity of acyclovirT Spector, D C Lobe, M N Ellis, et al.Journal of Environmental Science and Health. Part C: Environmental Health Sciences|January 1, 1979
Prenatal effects of 2,4,5-T, 2,4,5-trichlorophenol, and phenoxyacetic acid in miceR D Hood, B L Patterson, G T Thacker, et al.Pageof 2